Staphylococcus, coagulase negative
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | +-* |
Imipenem | +-* |
|
| Azithromycin | 41 |
Levofloxacin | 56 |
|
| Aztreonam | - |
Meropenem | +-* |
|
| Cefazolin | 44 |
Moxifloxacin | 69
|
|
| Cefepime | +/- |
Nitrofurantoin | &
|
|
| Ceftazidime | +/- |
Oxacillin/Naf | 44 |
|
| Ceftriaxone | 51 |
Penicillin | 9 |
|
| Cefuroxime | +/- |
Piperacillin | +/-
|
|
| Ciprofloxacin | 52 |
Piperacillin/tazo | +-* |
|
| Clarithromycin | +-* |
Ticarcillin/Clav | +-* |
|
| Clindamycin | 67 |
Tobramycin | +/- |
|
| Doxycycline | 83 |
TMP/SMX | 68 |
|
| Erythromycin | 38 |
Unasyn/Aug | 45 |
|
| Gentamicin | +/- |
Vancomycin | 100 |
|
Comments:
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
